Cross Border Mergers & Acquisitions Specialists

Sterling LeFevre

Sterling LeFevre

Mr. LeFevre moved to Shanghai China in 2003 from Santa Barbara California to pursue M&A Financial Advisory. In addition to M&A he guided numerous Chinese firms through the fund raising process from start up to Pre-IPO. Mr LeFevre has also advised numerous MNC on developing and executing their China strategy. His M&A efforts have resulted in transactions ranging from 10 to over 100 million USD.

Currently Mr LeFevre is a senior advisor on a large scale mixed use commercial real-estate development encompassing over 250,000 sqm & an investment  of over $50 m USD.

Prior to moving to Asia Mr. LeFevre, who is originally from Columbus Ohio, consulted on the successful launch and business development of Santa Barbara Market Neutral Fund,a fund of funds hedge fund. During that time period Mr. LeFevre also advised on numerous private equity placements and was instrumental in the founding of The Dream Foundation.

Tim O'Leary

Tim O’Leary

Prior to joining the Sterling Capital Team Mr. O’Leary worked as an investment analyst at Navis Capital Partners, a prestigious APAC Private Equity firm for over four years. Mr. O’Leary sourced, modeled, stress tested, preformed due diligence and structured deals, as well as grew and lead strategic initiatives at portfolio companies.

Mr. O’Leary holds a Bachelor of Science in Business Administration, with an Entrepreneurship emphasis and a Leadership Studies Minor, for which he was the valedictorian of his graduating class, from Chapman University in Southern California.

As a Thai citizen, educated both in Thailand and overseas, Mr. O’Leary not only has unique insights into the cultural and economic nuances of the region, he also reads writes and speaks fluent Thai and English.

Mr. O’Leary is the co-founding Director of multiple businesses in Thailand, including ‘Miracles Asia’, and ‘Lifestyle Juicery’

Justin Oh

Justin Oh

Mr. Oh worked as an investment manager at Xinhua Capital a boutique Investment Bank based in Shanghai which specialized in cross border M&A and fund raising prior to it’s rebranding as Sterling Capital. Justin worked on numerous successful M&A and fund raising transactions. Prior Mr. Oh completed a Bachelors degree in Commerce & Finance from the University of Toronto and a Chinese language intensive course at the prestigious Tsinghua University. His speciality is facilitating cross border transactions between the West, China and South Korea.

Rick Yang

Rick Yang

Rick Yang is a highly experienced and qualified  CFA level three finance professional. Rick’s positions include CEO of Roi Energy a Chinese publicly listed company involved in planning, engineering and  management company operations. Roi Energy provides one-stop energy auditing, planning, engineering, operation management, and cloud-based software services to various energy users.

Mr. Yang served as Managing Director of Xinhua Capital a boutique Investment Bank based in Shanghai which specialized in cross border M&A and fund raising prior to it’s rebranding as Sterling Capital.  Rick lead numerous successful M&A and fund raising transactions. Prior positions include Director of Xinhua Finance as well as Business Development Manager for Ping An Pension Insurance company of China.

Mr Yang holds a MBA from Boston University School of Management where he was Vice Chairman of the Chinese MBA Association.

Our Advisors

Sterling LeFevre

Health Care / Health & Wellness

George Baeder

Compelling, provocative thought partner and speaker on the corporate and public policy challenges accompanying China’s emergence as the world’s leading economy.

Economist, Strategist, Investment Banker, Entrepreneur who leverages 40 years experience in Asia helping US, European and Asian senior management teams identify and capture innovative growth opportunities in Emerging Markets

Advise and assist corporate leaders in creating and executing successful global strategies that leverage China both as a market and as a source of global competitive advantage

Deep expertise in pharmaceuticals, biotech, medical devices, diagnostics covering business development, market forecasting, regulatory environment, reimbursement, market access and new product planning

Focus:
Growth Strategy
Disruptive Innovation
Changing Rules of Global Competition
China/Asia Opportunity
Life Science Industry
M&A/PE/Partnerships